US20030220516A1 - Process for the preparation of substituted phenylboronic acids - Google Patents

Process for the preparation of substituted phenylboronic acids Download PDF

Info

Publication number
US20030220516A1
US20030220516A1 US10/425,389 US42538903A US2003220516A1 US 20030220516 A1 US20030220516 A1 US 20030220516A1 US 42538903 A US42538903 A US 42538903A US 2003220516 A1 US2003220516 A1 US 2003220516A1
Authority
US
United States
Prior art keywords
formula
alkyl
compound
diol
anthracene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/425,389
Inventor
Steffen Haber
Andreas Meudt
Stefan Scherer
Frank Vollmueller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clariant Produkte Deutschland GmbH
Original Assignee
Clariant GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clariant GmbH filed Critical Clariant GmbH
Priority to US10/425,389 priority Critical patent/US20030220516A1/en
Assigned to CLARIANT GMBH reassignment CLARIANT GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HABER, STEFFEN, MEUDT, ANDREAS, VOLLMUELLER, FRANK
Publication of US20030220516A1 publication Critical patent/US20030220516A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/02Magnesium compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Definitions

  • Phenylboronic acids for example cyanophenylboronic acids
  • cyanophenylboronic acids are of considerable industrial importance as precursors for active compounds, in particular as precursors for correspondingly substituted biphenyl derivatives, which are used as AT(II) antagonists, or as precursors for liquid-crystalline compounds, as liquid crystals or as a constituent of liquid-crystalline mixtures.
  • Phenylboronic acids can be coupled to haloaromatic compounds with transition-metal catalysis to give biphenyl derivatives with the aid of methods described in the literature (N. Miyaura et al., Tetrahedron Lett., 3437 (1979); A. L. Casalnuovo et al., J. Amer. Chem. Soc. 112, 4324 (1990), N. Miyaura et al., Chem. Rev. 95 (1995), 2457-2483).
  • WO 98/02 443 uses transition-metal compounds, if necessary in combination with co-catalysts, for activating aromatic chlorine compounds for Grignard reactions, but not for chlorinated aromatic aldehydes or protected derivatives thereof. Rather, it is known that ether and acetal protecting groups considerably reduce the reactivity of the magnesium by forming complexes at the magnesium surface (D. E. Pearson et al., J. Org. Chem., 1959, 24, 504-509).
  • Q 1 and Q 2 are each OH or together are a divalent radical of the formula (Ib)
  • Z is —CHO, D, —CH 2 Y or X, where D is a protected aldehyde group, Y is hydroxyl or amino, and X is cyano, COOH, COCl, CONH 2 or C(OR) 3 , where R is C 1 -C 5 -alkyl or phenyl, and where Z is in the ortho-, meta- or para-position to the boronic acid radical;
  • R 1 to R 4 independently of one another, are hydrogen, C 1 -C 12 -alkyl, C 2 -C 12 -alkenyl, C 2 -C 12 -alkynyl, C 3 -C 12 -cycloalkyl, (C 1 -C 12 -)-alkoxy, O-phenyl, O-benzyl, aryl, heteroaryl, fluorine, N(alkyl) 2 , N[Si(C 1 -C 4 -alkyl) 3 ] 2 or CF 3 , or R 1 and R 2 , and/or R 3 and R 4 , together form a 5-or 6-membered aliphatic or aromatic ring;
  • anthracene compound is a compound from the group consisting of anthracene, Mg anthracene, substituted anthracene and substituted Mg anthracene,
  • D 1 is CHO or D
  • Q 1 and Q 2 are each OH or together are a divalent radical of the formula (IVb)
  • alkyl is preferably C 1 -C 4 -alkyl
  • aryl is preferably phenyl
  • alkylaryl is preferably benzyl
  • alkoxy is preferably C 1 -C 4 -alkoxy
  • Preferred radicals R (Z is —C(OR) 3 ) are C 1 -C 4 -alkyl, in particular methyl, ethyl or phenyl.
  • Preferred radicals R 1 to R 4 are hydrogen, methyl, ethyl, propyl, butyl, methoxy, ethoxy, propoxy, butoxy and fluorine.
  • the radical D is preferably an acetal of the formula (V) or (VI)
  • R 5 to R 8 are identical or different and are hydrogen, C 1 -C 12 -alkyl or phenyl, or R 6 and R 7 together form a 5- or 6-membered aliphatic or aromatic ring; or D is an oxazolidine of the formula (VII) or an oxazoline of the formula (VIII)
  • R 5 to R 8 are as defined above, and R 9 is C 1 -C 6 -alkyl, phenyl or benzyl, unsubstituted or substituted on the aromatic ring.
  • Preferred borates B(OR′) 3 are trimethyl borate, triethyl borate, tri-n-propyl borate, triisopropyl borate, tri-n-butyl borate and triisobutyl borate.
  • the group D is, if desired, converted into a compound of the formula (I) in which Z is —CHO by acidic hydrolysis or (in the case of the oxazolines) by reduction followed by acidic hydrolysis. It is also possible to remove the aldehyde protecting group in a one-pot process and, without prior isolation of a compound of the formula (IV) in which D 1 is D, to obtain a compound of the formula (IV) in which D 1 is —CHO.
  • R 1 a to R 8 a independently of one another, are hydrogen, C 1 -C 12 -alkyl, C 1 -C 12 -hydroxyalkyl, C 2 -C 12 -alkenyl, C 2 -C 12 -alkynyl, C 3 -C 12 -cycloalkyl, (C 1 -C 12 )-alkoxy, O-phenyl, O-benzyl, aryl, heteroaryl, fluorine, chlorine, NH 2 , NH(alkyl), N(alkyl) 2 , N[Si(C 1 -C 4 -alkyl) 3 ] 2 or CF 3 , and/or two adjacent radicals R 1 a to R 8 a together form a 5- or 6-membered aliphatic or aromatic ring, and in which n is an integer from 2 to 12,
  • the compounds of the formula (IVa) can be converted back into compounds of the formula (IV) by acidic hydrolysis.
  • the compounds of the formula (la) can be converted back into compounds of the formula (I) by acidic hydrolysis.
  • the reaction of the compound of the formula (I) or of the formula (IV) with the alcohols on which the radicals Q 3 and Q 4 are based is advantageously carried out in the presence of an organic solvent which is inert toward the reaction participants, such as tetrahydrofuran, methyl tert-butyl ether, toluene, o-, m- or p-xylene, hexane or heptane, at a temperature of from 20° C. to the boiling point of the solvent used.
  • an organic solvent which is inert toward the reaction participants
  • an organic solvent which is inert toward the reaction participants
  • an organic solvent which is inert toward the reaction participants
  • tetrahydrofuran methyl tert-butyl ether, toluene, o-, m- or p-xylene, hexane or heptane
  • diols or other polyhydric alcohols it is also possible to use methanol, ethanol,
  • Preferred radicals Q 3 and Q 4 are —O-(C 1 -C 6 )alkyl, —O-(C 2 -C 6 )alkenyl, —O-(C 3 -C 6 )-alkynyl, —O-phenyl, —O-benzyl, or Q 3 and Q 4 , together with the boron atom, form a cyclic boronate with the alcohols ethylene glycol, 1,2-propanediol, 1,3-propanediol, 1,4-butanediol, 2,2-dimethylpropane-1,3-diol, pyrocatechol, pinacol, 2,3-dihydroxynaphthalene, 1,2-dihydroxycyclohexane, 1,3-dihydroxycyclopentane or 1,2-dihydroxycyclooctane.
  • radicals Q 3 and Q 4 together with the boron atom, form a cyclic boronate with the alcohols ethylene glycol, 1,3-propanediol, 2,2-dimethyl-1,3-diol, pinacol and pyrocatechol.
  • the trimeric compounds of the formula (Ib) or (IVb) can be prepared from the corresponding monomeric compounds of the formula (I) or (IV) respectively, for example by heating at from 40 to 100° C., preferably from 50 to 75° C.
  • the aldehyde group is firstly converted into a magnesium-unreactive form, for example into a cyclic or a cyclic acetal, preferably ethylene glycol acetal, dimethyl or diethyl acetal, an oxazolidine or an oxazoline.
  • Chlorobenzaldehydes can be reacted with 1,2-diols by conventional methods to give correspondingly substituted 1,3-dioxolanes of the general formula (V) or with trialkyl ortho-esters, such as trimethyl orthoformate, triethyl orthoformate, triisopropyl orthoformate or corresponding orthoacetates, to give acyclic acetals of the general formula (VI).
  • trialkyl ortho-esters such as trimethyl orthoformate, triethyl orthoformate, triisopropyl orthoformate or corresponding orthoacetates
  • acyclic acetals of the general formula (VI) Preference is given here to the reactions with ethylene glycol, pyrocatechol, trimethyl orthoformate, triethyl orthoformate or triisopropyl orthoformate.
  • Chlorobenzaldehydes can be reacted with 1,2-aminoalcohols which are monosubstituted on the nitrogen to give correspondingly substituted oxazolidines of the general formula (VII) by azeotropic distillation of the water of reaction (T. H. Fife, L. Hagopian, J. Am. Chem. Soc. 1968, 1007-1014).
  • Preferred aminoalcohols are N-methyl-2-aminoethanol, N-ethyl-2-aminoethanol, N-propyl-2-aminoethanol, N-butyl-2-aminoethanol, N-phenyl-2-aminoethanol, N-benzyl-2-aminoethanol, N-methyl-2-aminopropanol, N-ethyl-2-aminopropanol, N-propyl-2-aminopropanol, N-butyl-2-aminopropanol, particularly preferably N-ethyl-2-aminoethanol, N-butyl-2-aminoethanol, N-phenyl-2-aminoethanol, N-benzyl-2-amino-ethanol.
  • the anthracene compounds employed can be unsubstituted anthracene or Mg anthracene, substituted, for example by 1 to 4 (C 1 -C 4 )-alkyl groups or phenyl groups, anthracene or Mg anthracene, in particular 9,10-diphenylanthracene or Mg 9,10-diphenylanthracene.
  • the anthracene compounds can be added in amounts of from 0.5 to 100 mol %, preferably from 1 to 10 mol %, based on the haloaromatic compounds, or alternatively formed in situ.
  • the transition-metal halides are preferably chlorides or bromides, in particular FeCl 2 , MnCl 2 , FeBr 2 or MnBr 2 .
  • the transition-metal halides can be added in amounts of from 0.5 to 100 mol %, preferably from 1 to 10 mol %, based on the haloaromatic compounds.
  • Suitable magnesium halides are MgCl 2 and MgBr 2 . They can be added in amounts of from 0.5 to 100 mol %, preferably from 1 to 10 mol %, based on the haloaromatic compounds.
  • the Grignard reaction is preferably carried out at the boiling point of the corresponding solvent and under a protective-gas atmosphere.
  • Suitable solvents are usually tetrahydrofuran, diethyl ether, monoglyme and diglyme and a solution of N,N,N′,N′-tetramethylethylenediamine in toluene. It may be advantageous before commencement of the reaction to activate the magnesium by a method described in Y.-H.
  • the compound of the formula (III) is novel and is likewise a subject-matter of the present invention.
  • the compound of the formula (III) can be isolated by removing the solvent by distillation under a protective-gas atmosphere.
  • the compound of the formula (III) is reacted, preferably without interim isolation, with the borate of the formula B(OR′) 3 , in particular with B(OCH 3 ) 3 , B(OEt) 3 or B(OiPr) 3 , and subsequently hydrolyzed under aqueous conditions to give a compound of the formula (IV).
  • the reaction with the borate is advantageously carried out at a temperature of from ⁇ 80° C. to +20° C., preferably from ⁇ 50° C. to +10° C., in particular from ⁇ 25° C. to 0° C.
  • the borate is advantageously employed in a 1- to 1.5-fold molar amount, based on the Grignard compound.
  • the compound of the formula (IV) can subsequently be hydrolyzed under acidic conditions, for example using sulfuric acid at pH 0 to 3. If D is an acetal or oxazolidine group, a preferred procedure is, when the addition of the borate is complete, to add the reaction mixture to ice-water and to set the pH of the suspension to from 1 to 2, for example using sulfuric acid, giving the compound of the formula (IV) in which D 1 is CHO and Q 1 and Q 2 are each OH.
  • Oxazolines i.e. D is a radical of the formula (VIII)
  • alkyl halides for example methyl iodide, methyl bromide, ethyl iodide or ethyl bromide
  • dialkyl sulfates for example dimethyl sulfate or diethyl sulfate
  • complex metal hydrides such
  • Secondary products can be prepared as shown in Scheme 2 by oxidation or reduction of the aldehyde.
  • Q 10 and Q 20 are Q 1 and Q 2 , or Q 3 and Q 4 if the formylphenylboronic acid is esterified, before the oxidation or reduction, by the above-described method using an alcohol on which the radicals Q 3 and Q 4 are based, in an inert organic solvent. This is particularly advantageous if oxidation is subsequently carried out.
  • Carboxyphenylboronic acids can be obtained by hydrolysis of cyanophenylboronic acid, for example analogously to M. V. Sargent, J. Chem. Soc. Perkin Trans. 1, 1987 (1), 231.
  • Carboxamidophenylboronic acids can be prepared by a method described in Liu, K.-T.; et al., Synthesis 1988 (9), 715, starting from cyanophenylboronic acid using MnO 2 on silica gel and water in an organic solvent.
  • Carboxylic acid orthoester phenylboronic acids can be prepared by a method described in P. Hamann et al., Synthetic Commun. (1989) 19 (9-10.), 1509-1518, from cyanophenylboronic acid using the corresponding alcohol ROH with addition of anhydrous hydrogen chloride to give the corresponding orthoester, in which R can be C 1 -C 12 -alkyl or aryl, preferably methyl, ethyl or phenyl.
  • Methyleneaminophenylboronic acids can be prepared by a method described in B. S. Biggs et al., Org. Synth. 1947, 27, by hydrogenation using hydrogen and Raney nickel as catalyst.
  • a Grignard solution as obtained from Example 1 or 2 was added dropwise at ⁇ 50° C. to a suspension of 10.4 g (100 mmol) of trimethyl borate in 300 ml of THF over the course of 3 hours.
  • the white suspension was poured into 200 g of ice-water.
  • the suspension was adjusted to pH 1 to 2 using conc. H 2 SO 4 .
  • the phases were separated, giving 12.45 g (83 mmol) of 4-formylboronic acid.
  • Example 3 was repeated with a reaction temperature of ⁇ 15° C.: yield 11.85 g (79 mmol) of 4-formylboronic acid.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Compounds of the formula (I)
Figure US20030220516A1-20031127-C00001
in which
Q1 and Q2 are each OH or form a trimeric boric anhydride,
Z is CHO, CH2Y, X or a protected aldehyde group, and X is CN, COOH, COCl, CONH2 or C(OR)3, and Y is OH or NH2, and Z is in the o-, m- or p-position to the boronic acid radical,
are prepared by
a) reacting a compound of the formula (II)
Figure US20030220516A1-20031127-C00002
 with Mg in the presence of an anthracene compound and, if desired, a transition-metal halide and, if desired, an Mg halide or in the presence of a transition-metal halide and, if desired, an Mg halide, to give the corresponding arylmagnesium chloride,
b) reacting the latter with a borate of the formula B(OR′)3 and hydrolyzing the product, with removal of the aldehyde protecting group,
c) and, if desired, oxidizing or reducing the free aldehyde group.

Description

    CROSS-REFERENCES TO RELATED APPLICATIONS
  • The present invention is described in the German priority application No. DE 199 17 979.4, filed Apr. 21, 1999, which is hereby incorporated by reference as is fully disclosed herein. [0001]
  • BACKGROUND OF THE INVENTION
  • Substituted phenylboronic acids, for example cyanophenylboronic acids, are of considerable industrial importance as precursors for active compounds, in particular as precursors for correspondingly substituted biphenyl derivatives, which are used as AT(II) antagonists, or as precursors for liquid-crystalline compounds, as liquid crystals or as a constituent of liquid-crystalline mixtures. Phenylboronic acids can be coupled to haloaromatic compounds with transition-metal catalysis to give biphenyl derivatives with the aid of methods described in the literature (N. Miyaura et al., Tetrahedron Lett., 3437 (1979); A. L. Casalnuovo et al., J. Amer. Chem. Soc. 112, 4324 (1990), N. Miyaura et al., Chem. Rev. 95 (1995), 2457-2483). [0002]
  • The conventional synthetic routes for cyanophenylboronic acids, either starting from carboxyphenylboronic acid via the formation of the acid amide with subsequent formation of the cyano compound or starting from the correspondingly substituted bromobenzonitrile by reaction with organolithium compounds, such as butyllithium, followed by reaction with a trialkyl borate, do not achieve the object of an economical synthesis of cyanophenylboronic acids which is simple to carry out industrially, since firstly the synthetic route contains too many steps, and secondly, organolithium compounds are very expensive and hazardous to handle. [0003]
  • The Grignard reaction with chlorobenzaldehyde proceeds in low yields and very slowly, meaning that for industrial purposes, it was hitherto necessary to use expensive bromobenzaldehyde (H. Jendralla et al., Liebigs Ann. 1995, 1253-1257). [0004]
  • WO 98/02 443 uses transition-metal compounds, if necessary in combination with co-catalysts, for activating aromatic chlorine compounds for Grignard reactions, but not for chlorinated aromatic aldehydes or protected derivatives thereof. Rather, it is known that ether and acetal protecting groups considerably reduce the reactivity of the magnesium by forming complexes at the magnesium surface (D. E. Pearson et al., J. Org. Chem., 1959, 24, 504-509). [0005]
  • SUMMARY OF THE INVENTION
  • Owing to the interest in this class of substances, there is a need for an economical synthesis of substituted phenylboronic acids, in particular of cyanophenylboronic acids, which is simple to carry out industrially. [0006]
  • DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • This object is achieved by a process for the preparation of a compound of the formula (I) [0007]
    Figure US20030220516A1-20031127-C00003
  • in which [0008]
  • Q[0009] 1 and Q2 are each OH or together are a divalent radical of the formula (Ib)
    Figure US20030220516A1-20031127-C00004
  • Z is —CHO, D, —CH[0010] 2Y or X, where D is a protected aldehyde group, Y is hydroxyl or amino, and X is cyano, COOH, COCl, CONH2 or C(OR)3, where R is C1-C5-alkyl or phenyl, and where Z is in the ortho-, meta- or para-position to the boronic acid radical;
  • R[0011] 1 to R4, independently of one another, are hydrogen, C1-C12-alkyl, C2-C12-alkenyl, C2-C12-alkynyl, C3-C12-cycloalkyl, (C1-C12-)-alkoxy, O-phenyl, O-benzyl, aryl, heteroaryl, fluorine, N(alkyl)2, N[Si(C1-C4-alkyl)3]2 or CF3, or R1 and R2, and/or R3 and R4, together form a 5-or 6-membered aliphatic or aromatic ring;
  • which comprises [0012]
  • a) reacting a compound of the formula (II) [0013]
    Figure US20030220516A1-20031127-C00005
  • with magnesium in the presence of [0014]  
  • i) an anthracene compound and, if desired, a transition-metal halide and, if desired, a magnesium halide; or [0015]
  • ii) a transition-metal halide and, if desired, a magnesium halide, where the anthracene compound is a compound from the group consisting of anthracene, Mg anthracene, substituted anthracene and substituted Mg anthracene, [0016]
  • to give an arylmagnesium chloride of the formula (III) [0017]
    Figure US20030220516A1-20031127-C00006
  • b) reacting the compound of the formula (III) with a borate of the formula B(OR′)[0018] 3, in which R′ are identical to or different from one another and are straight-chain or branched (C1-C8)-alkyl radicals, phenyl radicals which are unsubstituted or substituted by one or two (C1-C4)-alkyl groups or (C1-C4)-alkoxy groups, in particular straight-chain or branched (C1-C4)-alkyl radicals or unsubstituted phenyl radicals, and hydrolyzing the product to give a compound of the formula (IV)
    Figure US20030220516A1-20031127-C00007
  • in which [0019]
  • D[0020] 1 is CHO or D;
  • Q[0021] 1 and Q2 are each OH or together are a divalent radical of the formula (IVb)
    Figure US20030220516A1-20031127-C00008
  • c) if desired oxidizing the compound of the formula (IV) or (IVb) in which D[0022] 1 is CHO to give a compound of the formula (I) in which Z is X, or if desired reducing the compound of the formula (IV) or (IVb) to give a compound of the formula (I) in which Z is CH2Y.
  • In the above definitions, alkyl is preferably C[0023] 1-C4-alkyl, aryl is preferably phenyl, alkylaryl is preferably benzyl, and alkoxy is preferably C1-C4-alkoxy.
  • Preferred radicals R (Z is —C(OR)[0024] 3) are C1-C4-alkyl, in particular methyl, ethyl or phenyl.
  • Preferred radicals R[0025] 1 to R4 are hydrogen, methyl, ethyl, propyl, butyl, methoxy, ethoxy, propoxy, butoxy and fluorine.
  • The radical D is preferably an acetal of the formula (V) or (VI) [0026]
    Figure US20030220516A1-20031127-C00009
  • in which R[0027] 5 to R8 are identical or different and are hydrogen, C1-C12-alkyl or phenyl, or R6 and R7 together form a 5- or 6-membered aliphatic or aromatic ring; or D is an oxazolidine of the formula (VII) or an oxazoline of the formula (VIII)
    Figure US20030220516A1-20031127-C00010
  • in which R[0028] 5 to R8 are as defined above, and R9 is C1-C6-alkyl, phenyl or benzyl, unsubstituted or substituted on the aromatic ring.
  • It was surprising that compounds of the formula (I) can be prepared in good yields by the process according to the invention starting from ortho-, meta- or para-chlorobenzaldehyde. [0029]
  • Preferred borates B(OR′)[0030] 3 are trimethyl borate, triethyl borate, tri-n-propyl borate, triisopropyl borate, tri-n-butyl borate and triisobutyl borate.
  • The group D is, if desired, converted into a compound of the formula (I) in which Z is —CHO by acidic hydrolysis or (in the case of the oxazolines) by reduction followed by acidic hydrolysis. It is also possible to remove the aldehyde protecting group in a one-pot process and, without prior isolation of a compound of the formula (IV) in which D[0031] 1 is D, to obtain a compound of the formula (IV) in which D1 is —CHO.
  • It is likewise possible, by reacting compounds of the formula (IV) with alcohols of the formula HO-(C[0032] 1-C12)-alkyl, HO-(C2-C12)-alkenyl, HO-(C2-C12)-alkynyl, HO-aryl or HO-alkylaryl, to prepare acyclic boronates of the formula (IVa)
    Figure US20030220516A1-20031127-C00011
  • in which Q[0033] 3 and Q4 are a radical of said alcohols,
  • or, by reaction with the polyhydric alcohols (C[0034] 3-C12)-cycloalkane-1,2-diol, (C5-C12)-cycloalkene-1,2-diol, (C5-C12)-cycloalkane-1,3-diol, (C5-C12)-cycloalkene-1,3-diol or with the alcohols of the formulae (1) to (6)
    Figure US20030220516A1-20031127-C00012
  • in which R[0035] 1a to R8a, independently of one another, are hydrogen, C1-C12-alkyl, C1-C12-hydroxyalkyl, C2-C12-alkenyl, C2-C12-alkynyl, C3-C12-cycloalkyl, (C1-C12)-alkoxy, O-phenyl, O-benzyl, aryl, heteroaryl, fluorine, chlorine, NH2, NH(alkyl), N(alkyl)2, N[Si(C1-C4-alkyl)3]2 or CF3, and/or two adjacent radicals R1a to R8a together form a 5- or 6-membered aliphatic or aromatic ring, and in which n is an integer from 2 to 12,
  • to prepare a cyclic borate of the formula (IVa) in which Q[0036] 3 and Q4 together are a divalent radical of said polyhydric alcohols.
  • The compounds of the formula (IVa) can be converted back into compounds of the formula (IV) by acidic hydrolysis. [0037]
  • The compounds of the formula (I) in which Z is CHO, X or —CH[0038] 2Y can likewise be converted into the compounds of the formula (la) by reaction with the above-mentioned alcohols.
    Figure US20030220516A1-20031127-C00013
  • The compounds of the formula (la) can be converted back into compounds of the formula (I) by acidic hydrolysis. [0039]
  • The reaction of the compound of the formula (I) or of the formula (IV) with the alcohols on which the radicals Q[0040] 3 and Q4 are based is advantageously carried out in the presence of an organic solvent which is inert toward the reaction participants, such as tetrahydrofuran, methyl tert-butyl ether, toluene, o-, m- or p-xylene, hexane or heptane, at a temperature of from 20° C. to the boiling point of the solvent used. In the case of diols or other polyhydric alcohols, it is also possible to use methanol, ethanol, n- or isopropanol as inert solvent. The diol on which the radicals Q3 and Q4 are based is advantageously employed in an equimolar amount, based on the boronic acid.
  • Preferred radicals Q[0041] 3 and Q4 are —O-(C1-C6)alkyl, —O-(C2-C6)alkenyl, —O-(C3-C6)-alkynyl, —O-phenyl, —O-benzyl, or Q3 and Q4, together with the boron atom, form a cyclic boronate with the alcohols ethylene glycol, 1,2-propanediol, 1,3-propanediol, 1,4-butanediol, 2,2-dimethylpropane-1,3-diol, pyrocatechol, pinacol, 2,3-dihydroxynaphthalene, 1,2-dihydroxycyclohexane, 1,3-dihydroxycyclopentane or 1,2-dihydroxycyclooctane.
  • Particularly preferred radicals Q[0042] 3 and Q4, together with the boron atom, form a cyclic boronate with the alcohols ethylene glycol, 1,3-propanediol, 2,2-dimethyl-1,3-diol, pinacol and pyrocatechol.
  • The trimeric compounds of the formula (Ib) or (IVb) can be prepared from the corresponding monomeric compounds of the formula (I) or (IV) respectively, for example by heating at from 40 to 100° C., preferably from 50 to 75° C. [0043]
  • The process according to the invention is shown in Scheme 1 below: [0044]
    Figure US20030220516A1-20031127-C00014
  • The aldehyde group is firstly converted into a magnesium-unreactive form, for example into a cyclic or a cyclic acetal, preferably ethylene glycol acetal, dimethyl or diethyl acetal, an oxazolidine or an oxazoline. [0045]
  • Chlorobenzaldehydes can be reacted with 1,2-diols by conventional methods to give correspondingly substituted 1,3-dioxolanes of the general formula (V) or with trialkyl ortho-esters, such as trimethyl orthoformate, triethyl orthoformate, triisopropyl orthoformate or corresponding orthoacetates, to give acyclic acetals of the general formula (VI). Preference is given here to the reactions with ethylene glycol, pyrocatechol, trimethyl orthoformate, triethyl orthoformate or triisopropyl orthoformate. [0046]
  • Chlorobenzaldehydes can be reacted with 1,2-aminoalcohols which are monosubstituted on the nitrogen to give correspondingly substituted oxazolidines of the general formula (VII) by azeotropic distillation of the water of reaction (T. H. Fife, L. Hagopian, J. Am. Chem. Soc. 1968, 1007-1014). Preferred aminoalcohols are N-methyl-2-aminoethanol, N-ethyl-2-aminoethanol, N-propyl-2-aminoethanol, N-butyl-2-aminoethanol, N-phenyl-2-aminoethanol, N-benzyl-2-aminoethanol, N-methyl-2-aminopropanol, N-ethyl-2-aminopropanol, N-propyl-2-aminopropanol, N-butyl-2-aminopropanol, particularly preferably N-ethyl-2-aminoethanol, N-butyl-2-aminoethanol, N-phenyl-2-aminoethanol, N-benzyl-2-amino-ethanol. [0047]
  • It is furthermore possible to react the correspondingly substituted chlorobenzoyl chloride with 1,2-aminoalcohols by a method described in J. Org. Chem. 1988, 53, 345-352, to give oxazolines. [0048]
    Figure US20030220516A1-20031127-C00015
  • Preference is given here to 2-amino-2-methylpropan-1-ol and 2-aminoethanol. [0049]
  • The compound of the formula (II) is converted in accordance with the invention into the Grignard compound of the formula (III) using Mg powder or turnings in the presence of [0050]
  • i) an anthracene compound or ii) an anthracene compound and a transition-metal halide or iii) an anthracene compound and a magnesium halide or iv) an anthracene compound, a transition-metal halide and a magnesium halide or v) a transition-metal halide or vi) a transition-metal halide and a magnesium halide. [0051]
  • The anthracene compounds employed can be unsubstituted anthracene or Mg anthracene, substituted, for example by 1 to 4 (C[0052] 1-C4)-alkyl groups or phenyl groups, anthracene or Mg anthracene, in particular 9,10-diphenylanthracene or Mg 9,10-diphenylanthracene. The anthracene compounds can be added in amounts of from 0.5 to 100 mol %, preferably from 1 to 10 mol %, based on the haloaromatic compounds, or alternatively formed in situ.
  • The transition-metal halides are preferably chlorides or bromides, in particular FeCl[0053] 2, MnCl2, FeBr2 or MnBr2. The transition-metal halides can be added in amounts of from 0.5 to 100 mol %, preferably from 1 to 10 mol %, based on the haloaromatic compounds.
  • Suitable magnesium halides are MgCl[0054] 2 and MgBr2. They can be added in amounts of from 0.5 to 100 mol %, preferably from 1 to 10 mol %, based on the haloaromatic compounds.
  • The Grignard reaction is preferably carried out at the boiling point of the corresponding solvent and under a protective-gas atmosphere. Suitable solvents are usually tetrahydrofuran, diethyl ether, monoglyme and diglyme and a solution of N,N,N′,N′-tetramethylethylenediamine in toluene. It may be advantageous before commencement of the reaction to activate the magnesium by a method described in Y.-H. Lai, Synthesis 585-604 (1981) or to carry out the Grignard reaction in the presence of small amounts, for example from 0.01 to 10 mol %, preferably from 0.1 to 1 mol %, based on the haloaromatic compounds, of a haloalkane, such as, for example, 1,2-dibromoethane, bromoethane or iodomethane. [0055]
  • The compound of the formula (III) is novel and is likewise a subject-matter of the present invention. The compound of the formula (III) can be isolated by removing the solvent by distillation under a protective-gas atmosphere. [0056]
  • In order to obtain phenylboronic acids, the compound of the formula (III) is reacted, preferably without interim isolation, with the borate of the formula B(OR′)[0057] 3, in particular with B(OCH3)3, B(OEt)3 or B(OiPr)3, and subsequently hydrolyzed under aqueous conditions to give a compound of the formula (IV). The reaction with the borate is advantageously carried out at a temperature of from −80° C. to +20° C., preferably from −50° C. to +10° C., in particular from −25° C. to 0° C.
  • The borate is advantageously employed in a 1- to 1.5-fold molar amount, based on the Grignard compound. [0058]
  • The compound of the formula (IV) can subsequently be hydrolyzed under acidic conditions, for example using sulfuric acid at pH 0 to 3. If D is an acetal or oxazolidine group, a preferred procedure is, when the addition of the borate is complete, to add the reaction mixture to ice-water and to set the pH of the suspension to from 1 to 2, for example using sulfuric acid, giving the compound of the formula (IV) in which D[0059] 1 is CHO and Q1 and Q2 are each OH.
  • Oxazolines, i.e. D is a radical of the formula (VIII), can be converted into the aldehyde by a method described in J. Am. Chem. Soc. 1983, 105, 1586-1590, by alkylation on the nitrogen using alkyl halides, for example methyl iodide, methyl bromide, ethyl iodide or ethyl bromide, or using dialkyl sulfates, for example dimethyl sulfate or diethyl sulfate, hydrogenation using complex metal hydrides, such as LiAlH[0060] 4, NaBH4 or NaBH3(CN), followed by acidic hydrolysis.
    Figure US20030220516A1-20031127-C00016
  • During the hydrolysis, the aldehyde predicting group is removed and the boronate is converted into the free boronic acid. The formylphenylboronic acid of the formula (I) in which Z is CHO can be isolated from the organic phase of the reaction mixture. [0061]
  • Secondary products can be prepared as shown in Scheme 2 by oxidation or reduction of the aldehyde. In this scheme, Q[0062] 10 and Q20 are Q1 and Q2, or Q3 and Q4 if the formylphenylboronic acid is esterified, before the oxidation or reduction, by the above-described method using an alcohol on which the radicals Q3 and Q4 are based, in an inert organic solvent. This is particularly advantageous if oxidation is subsequently carried out.
    Figure US20030220516A1-20031127-C00017
  • a) From formylphenylboronic acid and its borates, the corresponding cyanophenylboronic acid of the formula (I) in which Z is CN is obtained by reaction with hydroxylamine or hydroxylammonium salts followed by dehydration of the oxime formed. The dehydration can be carried out by heating in glacial acetic acid or in acetic anhydride (J. Chem. Soc. 1933, IX, 43). By a method proposed in EP-A1-0 790 234, the nitrile function is obtained by reaction of the benzaldehyde derivative with hydroxylamine sulfate in the presence of a tertiary amine base and azeotropic distillation of the water of reaction. [0063]
  • b) The corresponding carboxyphenylboronic acid of the formula (I) in which Z is COOH can be prepared by oxidation of formylphenylboronic acid using barium permanganate or potassium permanganate, for example in accordance with U.S. Pat. No. 5,631,364. [0064]
  • c) The compound of the formula (I) in which Z=CH[0065] 2OH can be obtained by reduction using Raney nickel/hydrogen or using complex metal hydrides, such as LiAlH4 or NaBH4.
  • d) The compound of the formula (I) in which Z=COCl can be obtained by a method described in Ginsburg, D., J. Amer. Chem. Soc., 1951, 73, 702-704, by reaction of formylphenylboronic acid with t-BuOCl in carbon tetrachloride. [0066]
  • Starting from cyanophenylboronic acid or borates, further secondary products can be prepared in accordance with Scheme 3.[0067]
  • EXAMPLES
  • [0068]
    Figure US20030220516A1-20031127-C00018
  • e) Carboxyphenylboronic acids can be obtained by hydrolysis of cyanophenylboronic acid, for example analogously to M. V. Sargent, J. Chem. Soc. Perkin Trans. 1, 1987 (1), 231. [0069]
  • f) Carboxamidophenylboronic acids can be prepared by a method described in Liu, K.-T.; et al., Synthesis 1988 (9), 715, starting from cyanophenylboronic acid using MnO[0070] 2 on silica gel and water in an organic solvent.
  • g) Carboxylic acid orthoester phenylboronic acids can be prepared by a method described in P. Hamann et al., Synthetic Commun. (1989) 19 (9-10.), 1509-1518, from cyanophenylboronic acid using the corresponding alcohol ROH with addition of anhydrous hydrogen chloride to give the corresponding orthoester, in which R can be C[0071] 1-C12-alkyl or aryl, preferably methyl, ethyl or phenyl.
  • h) Methyleneaminophenylboronic acids can be prepared by a method described in B. S. Biggs et al., Org. Synth. 1947, 27, by hydrogenation using hydrogen and Raney nickel as catalyst. [0072]
  • Example 1
  • 2.7 g (110 mmol) of magnesium turnings were added to a solution of 2 g (11 mmol) of anthracene in 100 ml of THF, and a few drops of 1,2-dibromoethane were added. After the mixture had been stirred at room temperature for about 2 hours, the bright orange precipitate of magnesium anthracene had formed. A solution of 19 g (100 mmol) of 4-chlorobenzaldehyde dimethyl acetal in 100 ml of THF was added to the refluxing suspension over the course of 1 hour. After the mixture had refluxed for 4 hours, the yield of Mg 4-chlorobenzaldehyde dimethyl acetal according to GC analysis (determined as benzaldehyde after hydrolysis using dilute HCl) was 90%. [0073]
  • Example 2
  • 100 ml of THF, 1.18 g (5.5 mmol) of anhydrous iron(II) bromide, 1.01 g (5.5 mmol) of magnesium bromide and a few drops of dibromoethane were added to 2.7 g (110 mmol) of magnesium turnings. After the mixture had been stirred at room temperature for about 2 hours, the mixture had become a dark-brown to black color. A solution of 19 g (100 mmol) of 4-chlorobenzaldehyde dimethyl acetal in 100 ml of THF was added to the refluxing suspension over the course of 1 hour. After the mixture had refluxed for 4 hours, the yield of Mg 4-chlorobenzaldehyde dimethyl acetal according to GC analysis (determined as benzaldehyde after hydrolysis using dilute HCl) was 95%. [0074]
  • Example 3 4-Formylboronic Acid
  • A Grignard solution as obtained from Example 1 or 2 was added dropwise at −50° C. to a suspension of 10.4 g (100 mmol) of trimethyl borate in 300 ml of THF over the course of 3 hours. When the addition was complete, the white suspension was poured into 200 g of ice-water. The suspension was adjusted to pH 1 to 2 using conc. H[0075] 2SO4. When the hydrolysis was complete, the phases were separated, giving 12.45 g (83 mmol) of 4-formylboronic acid.
  • Example 4
  • Example 3 was repeated with a reaction temperature of −15° C.: yield 11.85 g (79 mmol) of 4-formylboronic acid. [0076]
  • Example 5 4-(4,4,5,5-Tetramethyl[1,3,2]dioxaborolan-2-yl)benzaldehyde
  • A suspension of 5 g (33.3 mmol) of 4-formylphenylboronic acid and 3.93 g (33.3 mmol) of pinacol in 25 ml of toluene was refluxed on a water separator. When all the water of reaction had been removed, a clarifying filtration was carried out, and the solvent was removed by distillation until the product started to crystallize, giving 7.2 g (31 mmol) of product. [0077]
  • Example 6 4-Cyanophenylboronic Acid
  • 17 g (100 mmol) of hydroxylamine sulfate were added at 70° C. to 15 g (100 mmol) of 4-formylphenylboronic acid, 10 g of water, 5 g (60 mmol) of pyridine and 200 ml of toluene. The mixture was then refluxed on a water separator. When all the water had been removed, the pyridinium salts were separated off, giving 12.7 g (87%) of 4-cyanophenylboronic acid. [0078]
  • Example 7 Pinacolyl 4-cyanophenylboronate
  • 17 g (100 mmol) of hydroxylamine sulfate were added at 70° C. to 23.2 g (100 mmol) of pinacolyl 4-formylphenylboronate, 10 g of water, 5 g (60 mmol) of pyridine and 200 ml of toluene. The mixture was then refluxed on a water separator. When all the water had been removed, the pyridinium salts were separated off, giving 20.8 g (91%) of pinacolyl 4-cyanophenylboronate. [0079]
  • Example 8 4-Carboxyphenylboronic Acid
  • 14.5 g (100 mmol) of 4-cyanophenylboronic acid were dissolved in a mixture of 11 g (200 mmol) of potassium hydroxide and 10 g of water in 100 ml of methanol, and the mixture was refluxed until the evolution of ammonia gas was complete, giving 14.9 g (90 mmol) of 4-carboxyphenylboronic acid. [0080]
  • Example 9 Esterification of 4-carboxyphenylboronic Acid
  • 4-Carboxyphenylboronic acid and an equimolar amount of the appropriate diol shown in Table 1 were refluxed in 200 ml of toluene. When all the water formed had been removed on a water separator (after about 1 hour), the solution was filtered through a suction filter while still hot. The solvent was subsequently removed by distillation. [0081]
    TABLE 1
    Amount of
    starting
    Diol material Product Yield
    Pinacol 30 g 4-(4,4,5,5-Tetramethyl-  43.1 g (97%)
    (180 [1,3,2]dioxaborolan-2-yl)-
    mmol) benzoic acid
    Neopentyl 16.6 g 4-(5,5-Dimethyl-   22 g (94%)
    glycol (100 [1,3,2]dioxaborinan-2-yl)-
    mmol) benzoic acid
    Ethylene glycol 200 g 4-[1,3,2]Dioxaborolan-2-yl- 227.1 g (98%)
    (1.2 mol) benzoic acid
    Diethanolamine 20 g 4-[1,3,6,2]Dioxazaborocan-  27.5 g (98%)
    (120 2-yl-benzoic acid
    mmol)
  • Example 10 4-Carboxamidophenylboronic Acid
  • 10 g (68 mmol) of 4-cyanophenylboronic acid were refluxed for 6 hours in a mixture of 12 g (135 mmol) of manganese dioxide, 10 g of water and 150 ml of cyclohexane. 9.6 g (58 mmol) of 4-carboxamidophenylboronic acid were isolated. [0082]
  • Example 11 4-(Trimethoxymethyl)phenylboronic Acid
  • 30 g (203 mmol) of 4-cyanophenylboronic acid were dissolved in 200 ml of methanol, and 200 ml of 1 M hydrogen chloride solution in diethyl ether were added. The reaction mixture was refluxed for 8 hours, giving 38.5 g (170 mmol) 4-(trimethoxymethyl)phenylboronic acid [0083]
  • Example 12 4-(Methylamino)phenylboronic Acid
  • 30 g (203 mmol) of 4-cyanophenylboronic acid were dissolved in 200 ml of tetrahydrofuran, and 0.5 g of Raney nickel were added. A stream of hydrogen was passed through the reaction mixture for 8 hours, giving 29.8 g (199 mmol) of 4-(methylamino)phenylboronic acid. [0084]
  • Example 13 4-(Hydroxymethyl)phenylboronic Acid
  • 15 g (100 mmol) of 4-formylphenylboronic acid were dissolved in 200 ml of tetrahydrofuran, and 0.25 g of Raney nickel were added. A stream of hydrogen was passed through the reaction mixture for 8 hours, giving 14.8 g (97 mmol) of 4-(hydroxymethyl)phenylboronic acid. [0085]
  • Example 14 Pinacolyl 4-(hydroxymethyl)phenylboronate
  • Analogously to Example 12, 12 g (52 mmol) of pinacolyl 4-formylphenylboronate were hydrogenated in 100 ml of methanol, giving 11.7 g (50 mmol) of 4-(hydroxymethyl)phenylboronic acid. [0086]

Claims (11)

1. A process for the preparation of a compound of the formula (I)
Figure US20030220516A1-20031127-C00019
in which
Q1 and Q2 are each OH or together are a divalent radical of the formula (Ib)
Figure US20030220516A1-20031127-C00020
Z is —CHO, D, —CH2Y or X, where D is a protected aldehyde group, Y is hydroxyl or amino, and X is cyano, COOH, COCl, CONH2 or C(OR)3, where R is C1-C5-alkyl or phenyl, and where Z is in the ortho-, meta- or para-position to the boronic acid radical;
R1 to R4, independently of one another, are hydrogen, C1-C12-alkyl, C2-C12-alkenyl, C2-C12-alkynyl, C3-C12-cycloalkyl, (C1-C12-)-alkoxy, O-phenyl, O-benzyl, aryl, heteroaryl, fluorine, N(alkyl)2, N[Si(C1-C4-alkyl)3]2 or CF3, or R1 and R2, or R3 and R4, or R1 and R2, and R3 and R4 together form a 5- or 6-membered aliphatic or aromatic ring;
which comprises
a) reacting a compound of the formula (II)
Figure US20030220516A1-20031127-C00021
 with magnesium in the presence of
i) an anthracene compound and, optionally a transition-metal halide and, optionally, a magnesium halide; or
ii) a transition-metal halide and, optionally, a magnesium halide, where the anthracene compound is a compound from the group consisting of anthracene, Mg anthracene, substituted anthracene and substituted Mg anthracene, to give an arylmagnesium chloride of the formula (III)
Figure US20030220516A1-20031127-C00022
b) reacting the compound of the formula (III) with a borate of the formula B(OR′)3, in which R′ are identical to or different from one another and are straight-chain or branched (C1-C8)-alkyl radicals, phenyl radicals which are unsubstituted or substituted by one or two (C1-C4)-alkyl groups or (C1-C4)-alkoxy groups, and hydrolyzing the product to give a compound of the formula (IV)
Figure US20030220516A1-20031127-C00023
in which
D1 is CHO or D;
Q1 and Q2 are each OH or together are a divalent radical of the formula (IVb)
Figure US20030220516A1-20031127-C00024
c) optionally oxidizing the compound of the formula (IV) or (IVb) in which D1 is CHO to give a compound of the formula (I) in which Z is X, or optionally reducing the compound of the formula (IV) or (IVb) to give a compound of the formula (I) in which Z is CH2Y.
2. The process as claimed in claim 1, wherein R1 to R4 are hydrogen, methyl, ethyl, propyl, butyl, methoxy, ethoxy, propoxy, butoxy or fluorine.
3. The process as claimed in claim 1, wherein D is an acetal of the formula (V) or (VI)
Figure US20030220516A1-20031127-C00025
in which R5 to R8 are identical or different and are hydrogen, C1-C12-alkyl or phenyl, or R6 and R7 together form a 5- or 6-membered aliphatic or aromatic ring;
or D is an oxazolidine of the formula (VII) or an oxazoline of the formula (VIII)
Figure US20030220516A1-20031127-C00026
in which R9 is C1-C6-alkyl, phenyl or benzyl, unsubstituted or substituted on the aromatic ring.
4. The process as claimed in claim 1, wherein the borate B(OR′)3 is trimethyl borate, triethyl borate, tri-n-propyl borate, triisopropyl borate, tri-n-butyl borate and triisobutyl borate.
5. The process as claimed in claim 1, wherein step a) is carried out in the presence of anthracene, Mg anthracene, 9,10-diphenylanthracene or Mg 9,10-diphenylanthracene.
6. The process as claimed in claim 1, wherein step a) is carried out in the presence of MgCl2 or MgBr2, and in the presence of FeCl2, MnCl2, FeBr2 oder MnBr2.
7. The process as claimed in claim 1, wherein the compound of the formula (IV) is esterified using an alcohol of the formula HO-(C1-C12)-alkyl, HO-(C2-C12)-alkenyl, HO-(C2-C12)-alkynyl, HO-aryl, HO-alkylaryl, (C3-C12)-cycloalkane-1,2-diol, cycloalkane-1,2-diol, (C5-C12)-cycloalkene-1,2-diol, (C5-C12)-cycloalkane-1,3-diol, (C5-C12)-cycloalkene-1,3-diol or using an alcohol of the formulae (1) to (6)
Figure US20030220516A1-20031127-C00027
in which R1a to R8a, independently of one another, are hydrogen, C1-C12-alkyl, C1-C12-hydroxyalkyl, C2-C12-alkenyl, C2-C12-alkynyl, C3-C12-cycloalkyl, (C1-C12)-alkoxy, O-phenyl, O-benzyl, aryl, heteroaryl, fluorine, chlorine, NH2, NH(alkyl), N(alkyl)2, N[Si(C1-C4-alkyl)3]2 or CF3, two adjacent radicals R1a to R8a together optionally form a 5- or 6-membered aliphatic or aromatic ring, and in which n is an integer from 2 to 12.
8. The process as claimed in claim 1, wherein the compound of the formula (I) is esterified using an alcohol of the formula HO-(C1-C12)-alkyl, HO-(C2-C12)-alkenyl, HO-(C2-C12)-alkynyl, HO-aryl, HO-alkylaryl, (C3-C12)-cycloalkane-1,2-diol, cycloalkane-1,2-diol, (C5-C12)-cycloalkene-1,2-diol, (C5-C12)-cycloalkane-1,3-diol, (C5-C12)-cycloalkene-1,3-diol or using an alcohol of the formulae (1) to (6)
Figure US20030220516A1-20031127-C00028
in which R1a to R8a, independently of one another, are hydrogen, C1-C12-alkyl, C1-C12-hydroxyalkyl, C2-C12-alkenyl, C2-C12-alkynyl, C3-C12-cycloalkyl, (C1-C12)-alkoxy, O-phenyl, O-benzyl, aryl, heteroaryl, fluorine, chlorine, NH2, NH(alkyl), N(alkyl)2, N[Si(C1-C4-alkyl)3]2 or CF3, two adjacent radicals R1a to R8a together optionally form a 5- or 6-membered aliphatic or aromatic ring, and in which n is an integer from 2 to 12.
9. The process as claimed in claim 7, wherein, after the esterification, the aldehyde group is oxidized to the carboxyl, nitrile or carbonyl chloride group.
10. The process as claimed in claim 7, wherein, after the esterification, the aldehyde group is reduced to the methylamino or hydroxymethyl group.
11. An arylmagnesium chloride of the formula (III)
Figure US20030220516A1-20031127-C00029
in which R1 to R4, independently of one another, are hydrogen, C1-C12-alkyl, C2-C12-alkenyl, C2-C12-alkynyl, C3-C12-cycloalkyl, (C1-C12-)-alkoxy, O-phenyl, O-benzyl, aryl, heteroaryl, fluorine, N(alkyl)2, N[Si(C1-C4-alkyl)3]2 or CF3, or R1 and R2, or R3 and R4, or R1 and R2, and R3 and R4 together form a 5- or 6-membered aliphatic or aromatic ring,
and D is a protected aldehyde group.
US10/425,389 1999-04-21 2003-04-29 Process for the preparation of substituted phenylboronic acids Abandoned US20030220516A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/425,389 US20030220516A1 (en) 1999-04-21 2003-04-29 Process for the preparation of substituted phenylboronic acids

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19917979A DE19917979A1 (en) 1999-04-21 1999-04-21 Process for the preparation of substituted phenylboronic acids
DE19917979.4 1999-04-21
US09/553,036 US6576789B1 (en) 1999-04-21 2000-04-20 Process for the preparation of substituted phenylboronic acids
US10/425,389 US20030220516A1 (en) 1999-04-21 2003-04-29 Process for the preparation of substituted phenylboronic acids

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/553,036 Division US6576789B1 (en) 1999-04-21 2000-04-20 Process for the preparation of substituted phenylboronic acids

Publications (1)

Publication Number Publication Date
US20030220516A1 true US20030220516A1 (en) 2003-11-27

Family

ID=7905289

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/553,036 Expired - Fee Related US6576789B1 (en) 1999-04-21 2000-04-20 Process for the preparation of substituted phenylboronic acids
US10/425,389 Abandoned US20030220516A1 (en) 1999-04-21 2003-04-29 Process for the preparation of substituted phenylboronic acids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/553,036 Expired - Fee Related US6576789B1 (en) 1999-04-21 2000-04-20 Process for the preparation of substituted phenylboronic acids

Country Status (4)

Country Link
US (2) US6576789B1 (en)
EP (1) EP1046640A3 (en)
JP (1) JP2000336090A (en)
DE (1) DE19917979A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8410277B2 (en) 2007-12-26 2013-04-02 Eisai R&D Managment Co., Ltd. Method for manufacturing heterocycle substituted pyridine derivatives
CN112687880A (en) * 2020-12-28 2021-04-20 山东大学 Lithium-rich material, and modification method and application thereof

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50105269D1 (en) * 2000-12-14 2005-03-10 Clariant Gmbh PROCESS FOR THE PREPARATION OF FORMYLPHENYLBORONIC ACIDS
IL160010A0 (en) * 2001-07-23 2004-06-20 Univ Ramot Methods and compositions for treating fungal infections
DE10139664A1 (en) * 2001-08-11 2003-02-20 Clariant Gmbh Preparation of aryl- or alkyl-boron compounds via lithioaromatics or lithiated aliphatics is effected in microreactors with long, narrow capillaries to ensure intensive mixing and so reduce by-product content
DE10140857A1 (en) * 2001-08-21 2003-03-06 Clariant Gmbh Process for the preparation of aryl and alkyl boron compounds in microreactors
KR20040058340A (en) * 2001-11-30 2004-07-03 데이진 가부시키가이샤 Process for producing 5-(3-cyanophenyl)-3-formylbenzoic acid compound
US20090286995A1 (en) * 2006-04-21 2009-11-19 Andreas Meudt Method for the production of boronic acids carrying cyanoalkyl, carboxyl and aminocarbonyl groups and their derivatives
CN111171062A (en) * 2020-01-07 2020-05-19 大连双硼医药化工有限公司 Method for synthesizing 2-carboxyl sodium phenylboronate
CN111647011B (en) * 2020-07-16 2023-04-07 宁夏中星显示材料有限公司 Preparation method of monohalogenated phenylboronic acid

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162312A (en) * 1989-08-04 1992-11-10 Schering Aktiengesellschaft 11β-substituted 16α, 17α-methylene-estra-4,9-dien-3-ones
US6420597B2 (en) * 2000-07-01 2002-07-16 Clariant Gmbh Process for preparing highly pure formylphenylboronic acids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3038926A (en) * 1958-09-17 1962-06-12 Roussel Uclaf Organic diol aryl boronates
GB984363A (en) * 1961-06-23 1965-02-24 Wellcome Found Organic chemical compounds and methods
US5631364A (en) 1994-03-31 1997-05-20 Axis Biochemicals Asa Labelled boronic acid derivatives
FR2737721B1 (en) * 1995-08-08 1997-09-05 Roussel Uclaf NOVEL BIPHENYL COMPOUNDS, THEIR PREPARATION METHOD AND INTERMEDIATES THEREOF, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US5763638A (en) 1996-02-15 1998-06-09 Ciba Specialty Chemicals Corporation Preparation of aromatic nitriles
DE19628159A1 (en) 1996-07-12 1998-01-15 Studiengesellschaft Kohle Mbh Process for the synthesis of Grignard compounds using catalysts
DE19933833A1 (en) * 1999-07-20 2001-01-25 Bayer Ag Process for the production of Grignard reagents and new Grignard reagents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162312A (en) * 1989-08-04 1992-11-10 Schering Aktiengesellschaft 11β-substituted 16α, 17α-methylene-estra-4,9-dien-3-ones
US6420597B2 (en) * 2000-07-01 2002-07-16 Clariant Gmbh Process for preparing highly pure formylphenylboronic acids

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8410277B2 (en) 2007-12-26 2013-04-02 Eisai R&D Managment Co., Ltd. Method for manufacturing heterocycle substituted pyridine derivatives
CN112687880A (en) * 2020-12-28 2021-04-20 山东大学 Lithium-rich material, and modification method and application thereof

Also Published As

Publication number Publication date
DE19917979A1 (en) 2000-10-26
JP2000336090A (en) 2000-12-05
EP1046640A3 (en) 2002-07-24
EP1046640A2 (en) 2000-10-25
US6576789B1 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
US6576789B1 (en) Process for the preparation of substituted phenylboronic acids
Boudier et al. New applications of polyfunctional organometallic compounds in organic synthesis
Cirillo et al. Recent progress in the chemistry of acylsilanes. A review
Batey et al. Diastereoselective allylation and crotylation reactions of aldehydes with potassium allyl-and crotyltrifluoroborates under Lewis acid catalysis
Dembitsky et al. Recent developments in bisdiborane chemistry: B C B, B C C B, B C C B and B C C B compounds
Burkhardt et al. The direct preparation of organocadmium compounds from highly reactive cadmium metal powders
US20040039233A1 (en) Process for preparing bisallylboranes and nonaromatic boronic acids
US20110152523A1 (en) Catalyst for cross-coupling reaction, and process for production of aromatic compound using the same
Brown et al. Organoboranes. 41. Reaction of organoboranes with (dichloromethyl) lithium. Scope and limitations. Synthesis of homologated primary and secondary alcohols
CN110105382B (en) 1,1,2, 2-tetraborate ethylene and preparation method and application thereof
WO2009043300A1 (en) 1,2-disubstituted ruthenocene plane chirality ligand
TW201030014A (en) Process for the preparation of organo-oxazaborolidines
CA2616724C (en) A process for the preparation of bicyclo[3.1.0]hexanols
JP4118682B2 (en) Process for producing formylphenylboronic acid
CN113860990B (en) Alcohol synthesis method
JPH1059980A (en) Production of 5-bromo-2-fluorobenzeneboric acid
JP3818565B2 (en) Method for producing N-methylaniline derivative
Schmid et al. Some Observations Concerning the Thermally Induced Oxy‐Ene Reaction
JP2003081979A (en) New method for preparing organometallic compound
JP2005132817A (en) Method for producing pyridine-2-boronic acid ester
JP4040707B2 (en) Method for producing benzyl metal compound
Hossain Nickel-Catalyzed Hydroboration and Hydrosilylation
CN113735888A (en) Synthetic method of isopropenyl pinacol borate
Lannou et al. Organic synthesisOrganic synthesis
CN102408356A (en) Preparation method of docetaxel chiral side-chain intermediate

Legal Events

Date Code Title Description
AS Assignment

Owner name: CLARIANT GMBH, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HABER, STEFFEN;MEUDT, ANDREAS;VOLLMUELLER, FRANK;REEL/FRAME:014028/0865

Effective date: 20000321

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION